These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4166655)

  • 1. Antibodies directed to singly and doubly charged forms of the p-azobenzenearsonate group.
    Kitagawa M; Grossberg AL; Yagi Y; Pressman D
    Immunochemistry; 1967 Jul; 4(4):197-202. PubMed ID: 4166655
    [No Abstract]   [Full Text] [Related]  

  • 2. DIFFERENCES AMONG ANTIBODIES FORMED IN RESPONSE TO THE P-AZOVENZENEPHOSPHONATE AND P-AZOBENZENEARSONATE HAPTENS.
    KREITER VP; PRESSMAN D
    Biochemistry; 1964 Feb; 3():274-9. PubMed ID: 14163953
    [No Abstract]   [Full Text] [Related]  

  • 3. Affinity labeling anti-p-azobenzenearsonate antibodies using bromoacetyl derivatives of homologous hapten.
    Becker MJ; Givol D; Wilchek M
    Immunol Commun; 1973; 2(4):383-91. PubMed ID: 4583066
    [No Abstract]   [Full Text] [Related]  

  • 4. Antigenic competition in the development of delayed hypersensitivity to the azobenzenearsonate group.
    Schwartz H; Leskowitz S
    Immunochemistry; 1969 May; 6(3):503-6. PubMed ID: 4182366
    [No Abstract]   [Full Text] [Related]  

  • 5. Distribution of allelic allotypes among gamma-G-immunoglobulins and purified anti-hapten antibodies from the same rabbit.
    Lark CA; Eisen HN; Dray S
    J Immunol; 1965 Sep; 95(3):404-11. PubMed ID: 4158460
    [No Abstract]   [Full Text] [Related]  

  • 6. Ratios of the Fab fragments I and II from rabbit antibodies and non-specific gamma-globulins.
    Knight KL; Roelofs MJ; Haurowitz F
    Biochim Biophys Acta; 1967 Feb; 133(2):333-7. PubMed ID: 4166086
    [No Abstract]   [Full Text] [Related]  

  • 7. Detection of anti-p-azobenzenearsonate antibodies with chemically modified bacteriophage.
    Becker MJ; Conway-Jacobs A; Wilchek M; Haimovich J; Sela M
    Immunochemistry; 1970 Aug; 7(8):741-3. PubMed ID: 5488034
    [No Abstract]   [Full Text] [Related]  

  • 8. Peptides from the site of rabbit antibody: anti-3-azopyridine antibody.
    Friedenson B; Takeda Y; Roholt OA; Pressman D
    J Immunol; 1971 Oct; 107(4):957-64. PubMed ID: 4106096
    [No Abstract]   [Full Text] [Related]  

  • 9. Modification of arginine in the active sites of antibodies.
    Grossberg AL; Pressman D
    Biochemistry; 1968 Jan; 7(1):272-9. PubMed ID: 4098210
    [No Abstract]   [Full Text] [Related]  

  • 10. Antibody elution from hapten-cellulose immunoadsorbents: the effects of hapten structure, pH and salt concentration.
    Hoyer LW; Vannier WE; Renfer L
    Immunochemistry; 1968 May; 5(3):277-92. PubMed ID: 4174346
    [No Abstract]   [Full Text] [Related]  

  • 11. Electrophoresis of bovine serum at acid pH.
    Chang PK; Pincus G
    J Biol Chem; 1967 Jun; 242(12):2992-9. PubMed ID: 4165269
    [No Abstract]   [Full Text] [Related]  

  • 12. THE METABOLISM OF ANTIGEN IN VIVO. II. AZOPROTEIN.
    LAROSE A; ROSE B; RICHTER M
    Can J Biochem; 1964 Jun; 42():833-9. PubMed ID: 14196171
    [No Abstract]   [Full Text] [Related]  

  • 13. Isolation and characterization of electrophoretically homogeneous rabbit antihapten antibody populations. II. A survey of the isoelectric properties of antihapten antibodies directed against charged and uncharged haptens.
    Painter RH; Freedman MH
    J Biol Chem; 1971 Nov; 246(21):6692-9. PubMed ID: 4108928
    [No Abstract]   [Full Text] [Related]  

  • 14. Thermodynamics of the binding of haptens to rabbit anit-2,4-dinitrophenyl antibodies.
    Barisas BG; Sturtevant JM; Singer SJ
    Biochemistry; 1971 Jul; 10(15):2816-21. PubMed ID: 5114526
    [No Abstract]   [Full Text] [Related]  

  • 15. Recovery of antibody activity from inactive hybrids of H and L chains.
    Roholt OA; Radzimski G; Pressman D
    J Exp Med; 1967 Jan; 125(1):191-7. PubMed ID: 4163359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-p-azobenzenearsonate antibody of restricted heterogeneity. II. Idiotypes of antibodies produced during a 33-month period.
    Winfield JB; Mage RG; Alexander CB
    J Immunol; 1973 Mar; 110(3):729-35. PubMed ID: 4540132
    [No Abstract]   [Full Text] [Related]  

  • 17. Distribution of antibody affinities. II. Fractionation of antibody with respect to its hapten binding affinity.
    Kim YT; Werblin TP; Siskind GW
    Immunochemistry; 1974 Nov; 11(11):685-90. PubMed ID: 4142446
    [No Abstract]   [Full Text] [Related]  

  • 18. Production and properties of mouse antihapten antibodies.
    Mattioli CA; Yagi Y; Pressman D
    J Immunol; 1968 Nov; 101(5):939-48. PubMed ID: 4177055
    [No Abstract]   [Full Text] [Related]  

  • 19. IgM and IgG anti-hapten antibody: hemolytic, hemagglutinating and precipitating activity.
    Onoue K; Tanigaki N; Yagi Y; Pressman D
    Proc Soc Exp Biol Med; 1965 Nov; 120(2):340-6. PubMed ID: 4159255
    [No Abstract]   [Full Text] [Related]  

  • 20. Isolation and characterization of electrophoretically homogeneous rabbit antihapten antibody populations. 3. NH 2 -terminal light chain sequence analyses of focused anti-p-azophenyltrimethylammonium and anti-p-azobenzenearsonate antibody fractions.
    Freedman MH; Guyer RB; Terry WD
    J Biol Chem; 1972 Nov; 247(21):7051-61. PubMed ID: 4117158
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.